CIK 0001023549 · Non-accelerated filer
XTL BIOPHARMACEUTICALS LTD
Sign in to watch- Ticker
- XTLB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- Incorporated
- Israel
- Entity type
- other
- Phone
- 972 9 955 7080
- Business address
- XTL BIOPHARMACEUTICALS LTD, C/O ALSTON & BIRD LLP, 90 PARK AVENUE, NEW YORK, NY, 10016
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2008-01-02 | EDELMAN JOSEPH 10% owner | Purchase | +1,222,000 | $2.89 | $3.5M | 35,045,270 |
| 2007-12-31 | EDELMAN JOSEPH 10% owner | Purchase | +1,081,000 | $2.74 | $3.0M | 33,823,270 |
| 2007-12-31 | EDELMAN JOSEPH 10% owner | Purchase | +69,000 | $2.74 | $189K | 1,571,500 |
| 2007-12-30 | WEISS MICHAEL S Director | Gift · OPTIONS TO PURCHASE ORDINARY SHARES | −3,083,333 | $0.36 | $1.1M | 9,666,667 |
| 2007-12-28 | EDELMAN JOSEPH 10% owner | Purchase | +752,000 | $2.69 | $2.0M | 32,742,270 |
| 2007-12-28 | EDELMAN JOSEPH 10% owner | Purchase | +48,000 | $2.69 | $129K | 1,502,500 |
| 2007-12-27 | EDELMAN JOSEPH 10% owner | Purchase | +282,000 | $2.60 | $732K | 31,990,270 |
| 2007-12-27 | EDELMAN JOSEPH 10% owner | Purchase | +18,000 | $2.60 | $47K | 1,454,500 |
| 2007-08-21 | BENTSUR RON CEO | Purchase | +15,279 | $1.30 | $20K | 20,101 |
| 2007-01-08 | EDELMAN JOSEPH 10% owner | Purchase | +470,000 | $3.26 | $1.5M | 37,490,670 |
| 2007-01-02 | EDELMAN JOSEPH 10% owner | Purchase | +78,000 | $2.89 | $225K | 1,649,500 |
| 2006-08-25 | BENTSUR RON CEO | Purchase | +1,600 | $2.98 | $5K | 4,822 |
| 2005-01-04 | EDELMAN JOSEPH 10% owner | Purchase | +188,000 | $3.15 | $592K | 35,468,270 |
Page 10 of 10 · 193 trades